Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.47 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.47 |
| ▸ | FYN | P06241 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | AHR | P35869 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | HPGD | P15428 | 5/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30203231 | 1.00 | CYP1A2 (0.47) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL13080593 | 0.85 | CYP1A2 (0.53) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL224652 | 0.79 | ALDH1A1 (0.54) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL29840683 | 0.79 | ALDH1A1 (0.54) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL12431985 | 0.74 | CYP1A2 (0.34) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL31150378 | 0.74 | CYP1A2 (0.34) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL1816279 | 0.73 | ALDH1A1 (0.54) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL5162965 | 0.71 | CYP1A2 (0.47) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL1816278 | 0.70 | CYP1A2 (0.65) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL31544308 | 0.70 | ALDH1A1 (0.44) | CYP1A2ERBB2FYNMAOAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11213800-B2 | Covalent organic framework films, and methods of making and uses of same | CORNELL UNIVERSITY (US) | 2022-01-04 | — | — | US | disclosed |
| EP-2419489-B1 | ORGANIC LIGHT-EMITTING MATERIALS AND DEVICES | CAMBRIDGE DISPLAY TECH LTD (GB) | 2017-08-09 | — | — | EP | disclosed |
| EP-2326695-B1 | BLUE-LIGHT EMITTING MATERIAL | CAMBRIDGE DISPLAY TECH LTD (GB) | 2015-02-25 | — | — | EP | disclosed |
| US-20140148596-A1 | Covalent Organic Frameworks and Methods of Making Same | CORNELL UNIVERSITY (US) | 2014-05-29 | — | — | US | disclosed |
| US-20140037944-A1 | COVALENT ORGANIC FRAMEWORK FILMS, AND METHODS OF MAKING AND USES OF SAME | CORNELL UNIVERSITY (US) | 2014-02-06 | — | — | US | disclosed |
| US-8604464-B2 | Blue light-emitting material | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2013-12-10 | — | — | US | disclosed |
| US-20120085994-A1 | Organic Light-Emitting Materials and Devices | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2012-04-12 | — | — | US | disclosed |
| WO-2012037090-A2 | COVALENT ORGANIC FRAMEWORK FILMS, AND METHODS OF MAKING AND USES OF SAME | CORNELL UNIVERSITY (US) | 2012-03-22 | — | — | WO | disclosed |
| EP-2419489-A1 | ORGANIC LIGHT-EMITTING MATERIALS AND DEVICES | Cambridge Display Technology Limited (GB) | 2012-02-22 | — | — | EP | disclosed |
| WO-2011127301-A2 | COVALENT ORGANIC FRAMEWORKS AND METHODS OF MAKING SAME | CORNELL UNIVERSITY (US) | 2011-10-13 | — | — | WO | disclosed |
| US-20110186828-A1 | Blue light-Emitting Material | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2011-08-04 | — | — | US | disclosed |
| WO-2010119276-A1 | ORGANIC LIGHT-EMITTING MATERIALS AND DEVICES | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2010-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110186828-A1 | Blue light-Emitting Material | CRY1, CRY2, MAP1LC3A | CYP1A2 294/4885ERBB2 2371/4885FYN 3302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.